Abstract
Objectives: The objective is to see the effectiveness of hydrocortisone (HC)-ethanol gel (EG) ointment in treating children with Moderate-to-severe atopic dermatitis (AD). Methods: Thirty children with moderate-to-severe AD participated in a 2-week double-blind, randomized, and controlled clinical trial. They were randomly assigned to apply either an ointment with 1% HC ointment or a novel ointment containing 1% HC and dispersed EG droplets HC. At the end of 2 week, SCORAD score was measured. SCORAD is a clinical tool used to assess the extent and severity of eczema (SCORing AD). Results: A 2-week double-blind, randomized, and controlled clinical trial included 30 kids with moderate-to-severe AD. About 1% HC ointment or a new ointment comprising 1% HC and dispersed EG droplets were applied to them at random (HC-EG). The SCORAD score was calculated at the conclusion of 2 weeks. A clinical tool called SCORAD is used to evaluate the severity and extent of eczema (SCORing AD). Conclusion: We would want to draw the conclusion from our research that HC-EG ointment was superior to HC ointment in terms of reducing AD-related pruritus and visible rash.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Asian Journal of Pharmaceutical and Clinical Research
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
